4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-028377
Chairman and CEO bought 7,850 shares at an average $1.26 ($9,911)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-05-07 | Purchase | +2,950 | $1.25 | $3,688 | 10,617,193 | D |
| Niihara Yutaka Chairman and CEO | 2020-05-08 | Purchase | +4,900 | $1.27 | $6,223 | 10,622,093 | D |
| Open-market purchases · 7,850 sh · avg $1.26 · $9,911 | |||||||
Loading xslF345X03/doc4.xml…